Atlas Trials

Graft-Versus-Host Disease (GVHD) Prophylaxis After Allogeneic Peripheral Blood Hematopoietic Cell Transplantation

Clinical trial NCT00803010 · COMPLETED

Trial details

NCT number
NCT00803010
Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Acute Graft Versus Host Disease
Start date
2008-09-01
Primary completion
2012-12-01
Enrollment
74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.